Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines

被引:76
作者
Wandzioch, E
Edling, CE
Palmer, RH
Carlsson, L
Hallberg, B [1 ]
机构
[1] Umea Univ, Dept Med Biosci Pathol, S-90187 Umea, Sweden
[2] Umea Ctr Mol Med, Umea Ctr Mol Pathogenesis, Umea, Sweden
关键词
D O I
10.1182/blood-2003-07-2554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Steel factor (SF) and its receptor c-Kit play a critical role for various cell types at different levels in the hematopoietic hierarchy. Whether similar or distinct signaling pathways are used upon c-Kit activation in different cell types within the hematopoietic hierarchy is not known. To study c-Kit signaling pathways in the hematopoietic system we have compared c-Kit downstream signaling events in SF-dependent hematopoietic stem cell (HSC)-like cell lines to those of mast cells. Both Erk and protein kinase B (PKB)/Akt are activated by ligand-induced activation of the c-Kit receptor in the HSC-like cell lines. Surprisingly, phosphoinositide-3 (PI-3) kinase inhibitors block not only PKB/Akt activation but also activation of Raf and Erk. SF-induced activation of Ras is not affected by inhibition of PI-3 kinase. In mast cells and other more committed hematopoietic precursors, the activation of Erk by SF is not PI-3 kinase dependent. Our results suggest that a molecular signaling switch occurs during differentiation in the hematopoietic system whereby immature hematopoietic progenitor/stem cells use a PI-3 kinase-sensitive pathway in the activation of both Erk and PKB/Akt, which is then switched upon differentiation to the more commonly described PI-3 kinase-independent mitogen-activated protein (MAP) kinase pathway. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 50 条
[1]   Effects of mutant c-Kit in early myeloid cells [J].
Ashman, LK ;
Ferrao, P ;
Cole, SR ;
Cambareri, AC .
LEUKEMIA & LYMPHOMA, 1999, 34 (5-6) :451-461
[2]   Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells) [J].
Bao, HF ;
Jacobs-Helber, SM ;
Lawson, AE ;
Penta, K ;
Wickrema, A ;
Sawyer, ST .
BLOOD, 1999, 93 (11) :3757-3773
[3]  
BARKER JE, 1994, EXP HEMATOL, V22, P174
[4]   INCREASED KIT/SCF RECEPTOR-INDUCED MITOGENICITY BUT ABOLISHED CELL MOTILITY AFTER INHIBITION OF PROTEIN-KINASE-C [J].
BLUMEJENSEN, P ;
SIEGBAHN, A ;
STABEL, S ;
HELDIN, CH ;
RONNSTRAND, L .
EMBO JOURNAL, 1993, 12 (11) :4199-4209
[5]   STEEL-DICKIE MUTATION ENCODES A C-KIT LIGAND LACKING TRANSMEMBRANE AND CYTOPLASMIC DOMAINS [J].
BRANNAN, CI ;
LYMAN, SD ;
WILLIAMS, DE ;
EISENMAN, J ;
ANDERSON, DM ;
COSMAN, D ;
BEDELL, MA ;
JENKINS, NA ;
COPELAND, NG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :4671-4674
[6]  
BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480
[7]   THE PROTO-ONCOGENE C-KIT ENCODING A TRANSMEMBRANE TYROSINE KINASE RECEPTOR MAPS TO THE MOUSE W-LOCUS [J].
CHABOT, B ;
STEPHENSON, DA ;
CHAPMAN, VM ;
BESMER, P ;
BERNSTEIN, A .
NATURE, 1988, 335 (6185) :88-89
[8]   THE INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN OR INSULIN-LIKE GROWTH-FACTOR-1 IN THE RAT SKELETAL-MUSCLE CELL-LINE-L6 IS BLOCKED BY WORTMANNIN, BUT NOT BY RAPAMYCIN - EVIDENCE THAT WORTMANNIN BLOCKS ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY IN L6-CELLS BETWEEN RAS AND RAF [J].
CROSS, DAE ;
ALESSI, DR ;
VANDENHEEDE, JR ;
MCDOWELL, HE ;
HUNDAL, HS ;
COHEN, P .
BIOCHEMICAL JOURNAL, 1994, 303 :21-26
[9]  
DOPINTO OP, 2001, EXP HEMATOL, V29, P1019
[10]   Conditional inhibition of the mitogen-activated protein Kinase cascade by wortmannin - Dependence of signal strength [J].
Duckworth, BC ;
Cantley, LC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :27665-27670